Additional lots will be available.  Product will be made available as it is released.

Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 0641-6261-01)


Discontinuation of the manufacture of the drug

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Cytochrome P450 3A4 Inducers [MoA]
Cytochrome P450 1A2 Inducers [MoA]
Cytochrome P450 2B6 Inducers [MoA]
Cytochrome P450 2C9 Inducers [MoA]
Cytochrome P450 2C19 Inducers [MoA]

Carbatrol, Capsule, Extended Release, 100 mg (NDC 54092-171-12)


Inventory available at Cardinal Health, McKesson, Cencora (FKA Amerisource Bergen). Product (LIDOCAINE HCL 2% 10X2ML)  is Preservative free.

Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 83090-004-10)


Doxycycline Hyclate, Tablet, 100 mg (NDC 0378-0167-13)

Mylan Pharmaceuticals Inc., a Viatris Company


A business decision was made to discontinue manufacture of the drug.

Humalog, Injection, U-100 Tempo Pen (NDC 0002-8213-05)


Naropin, Injection, 10 mg/1 mL (NDC 63323-288-20)


Additional lots are currently in the manufacturing process and will be available upon release.

Increased Diuresis at Loop of Henle [PE]

Bumetanide, Injection, 2.5 mg/10 mL (0.25 mg/mL) (NDC 83301-0081-2)


Hydroxocobalamin, Injection, 1000 MCG/ML, 30 ML Multi-Dose Vial (NDC 0591-2888-30)


Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0054-0373-25)


Proton Pump Inhibitors [MoA]
Cytochrome P450 2C19 Inhibitors [MoA]

Omeprazole, Delayed Release Capsule, 20 mg (NDC 0781-2868-31)


Accupril, Tablet, 40 mg (NDC 0071-0535-23)


The 10 mg presentation remains available.

Vecuronium Bromide, Injection, 20 mg (NDC 47335-932-44)


Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0641-6041-25)


Discontinuation of the manufacture of the drug.

Zithromax IV, Injection, 500 mg/5 mL (NDC 0069-3150-83)


Corticosteroid Hormone Receptor Agonists [MoA]


Product temporarily on backorder.  Additional lots will be available in the May 2026 timeframe.

Infumorph 200 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 10 mg/1 mL (NDC 0641-6039-01)


Pemetrexed Disodium, Injection, 500 mg/20 mL (NDC 0781-3519-90)


Pravastatin Sodium, Tablet, 20 mg (NDC 0093-7201-10)


Tobramycin, Solution, 300 mg/4 mL (NDC 0093-3750-28)


Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/250 mL (3.2 mg/1 mL) (NDC 0409-7810-22)


Inventory available in vial presentations.

Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6026-05)


Irinotecan Hydrochloride, Injection, 100 mg/5 mL (NDC 50742-402-05)


Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE

AMPHETAMINE ASPARTATE MONOHYDRATE
AMPHETAMINE SULFATE
DEXTROAMPHETAMINE SACCHARATE
DEXTROAMPHETAMINE SULFATE

Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 42806-344-01)


Nebivolol Hydrochloride, Tablet, 20 mg (NDC 13668-356-90)


Dibenzyline, Capsule, 10 mg (NDC 66993-066-02)


International Medication Systems, Limited

Atropine Sulfate, Injection, .1 mg/1 mL (NDC 76329-3340-1)


Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-02)


Euthyrox, Tablet, 150 ug (NDC 72305-150-90)


Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-07)


Methylphenidate Hydrochloride Tablet, Extended Release

Methylin Er, Tablet, Extended Release, 54 mg (NDC 0406-0154-01)


DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE


The NDC codes are being discontinued, to be replaced with NDC labeler code #46163.

DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE

Fresenius Medical Care de Mexico, S.A. de C.V.

CALCIUM CHLORIDE
DEXTROSE MONOHYDRATE
MAGNESIUM CHLORIDE
SODIUM CHLORIDE
SODIUM LACTATE

DELFLEX® w/Dextrose, Solution, 1.5% Low Mg/Low Ca 2L, 5/cs (NDC 46163-206-92)


A business decision was made to discontinue manufacture of the drug

Calcitriol, Capsule, .5 ug (NDC 0093-7353-01)


Decreased Sebaceous Gland Activity [PE]
Neuromuscular Blockade [PE]

Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 72572-076-24)


For orders, Solco Healthcare 866-931-9829

Clonazepam, Tablet, .5 mg (NDC 43547-406-10)


Next Delivery: May 2026; Estimated Recovery: June 2026; Shortage per Manufacturer: Manufacturing Delay

Lorazepam, Injection, 2 mg/1 mL Syringes (NDC 0409-1985-30)


Please check wholesalers and distributors for inventory.

Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-611-10)


Marcaine, Injection, Marcaine 150 mg/30 mL (5 mg/mL) (NDC 0409-1560-29)


Clonazepam, Tablet, 2 mg (NDC 16729-138-00)


Next Delivery: July 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay

Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 0409-1630-10)


Supply expected to exhaust late June 2026; Discontinuation of the manufacture of the drug

Cisatracurium Besylate, Injection, 200 mg/20ml (10 mg/mL) Single Dose Vial (NDC 0409-1103-01)


Product expected to be available until August 2025.

Isoniazid, Tablet, 300 mg (NDC 64950-217-10)


Lidocaine Hydrochloride In Plastic Container, Injection, 200 mg/20 mL (1%; 10 mg/mL) (NDC 0409-4276-01)


Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 42858-165-01)


Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-604-01)


Sodium Oxybate, Solution, .5 g/1 mL (NDC 69238-2391-1)


Naltrexone Hydrochloride, Tablet, 50 mg (NDC 64850-300-30)


Potassium Chloride Tablet, Extended Release

Discontinuation of the manufacture of the drug product

Klor-Con, Tablet, Extended Release, 600 mg (NDC 0245-5315-01)


Distributed by BPI Labs, LLC; Customer service number: (727) 471-0850 Ext 270

Estimated recovery: end of June 2026; Distributed by BPI Labs, LLC

Carboplatin, Injection, 600 mg/65 mL (NDC 54288-167-01)


Amantadine Hydrochloride, Tablet, 100 mg (NDC 0832-0111-03)


Cefotaxime Sodium, Powder, for Solution, 500 mg (NDC 0143-9930-10)


Clonazepam, Tablet, .5 mg (NDC 72888-152-30)


Anticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility.

Flurazepam Hydrochloride, Capsule, 30 mg (NDC 0378-4430-01)


Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-5160-10)


Hydrocortisone Sodium Succinate Injection

Pulmonary/Allergy Dermatology Endocrinology/Metabolism Gastroenterology Hematology Neurology Oncology Ophthalmology Pediatric Renal Rheumatology

Solu-cortef, Injection, 500 mg/vial (NDC 0009-0016-12)


Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 70010-114-01)


Vyvanse, Capsule, 70 mg (NDC 59417-107-10)


Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 0555-0776-02)


Discontinuation of the manufacture of the drug

Morphine Sulfate, Tablet, 15 mg (NDC 0832-0273-11)


Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-10)


Distributed by BPI Labs, LLC;  Customer service number:  (727) 471-0850 Ext 270

Discontinued; Distributed by BPI Labs, LLC

Carboplatin, Injection, 50mg/5mL (NDC 54288-164-01)

Discontinuation of the manufacture of the drug


Haloperidol Decanoate, Injection, 50 mg/1 mL (NDC 63323-469-05)


Hydrochlorothiazide; Quinapril Hydrochloride Tablet


Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-01)


Lidocaine Hydrochloride In Plastic Container, Injection, 500 mg/50 mL (1%; 10 mg/mL) (NDC 0409-4276-02)


Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 60505-4745-1)


Check wholesalers for inventory; Marketed by Baxter

Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 43066-015-10)


Product can be manufactured as requested

Sterile Water, Injection, 1 mL/1 mL (NDC 0487-6105-01)


Decitabine, Injection, 50 mg (NDC 50742-430-01)


Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01)


Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 65162-026-09)


Demerol, Injection, 50 mg/1 mL (NDC 0409-1181-30)


Glyburide (Micronized), Tablet, 3 mg (NDC 0093-8035-01)


Endocrinology/Metabolism Gastroenterology Other Pediatric

Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0062-30)


Doxycycline Hyclate, Tablet, 100 mg (NDC 0591-5553-05)


Fresenius Medical Care Renal Therapies Group, LLC

DELFLEX® w/Dextrose, Solution, 2.5% Low Mg/Low Ca 2L, 5/cs (NDC 49230-209-92)


609-395-8625 ext. 203 (US Agent eVenus Pharmaceutical Laboratories, Inc.)

Discontinuation of the manufacture of the drug; Distributed by Sandoz Inc.

Fondaparinux Sodium, Injection, 2.5 mg/.5 mL (NDC 0781-3443-95)

Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)


(866) 850-2876 or CustomerService@AurobindoUSA.com

Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 13107-068-01)


Next release May 2026. Check wholesalers for inventory.

Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 63323-161-01)


Accupril, Tablet, 20 mg (NDC 0071-0532-23)


Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 67457-251-02)


Ativan, Injection, 4 mg/1 mL (NDC 0641-6003-25)


Discontinuation of the manufacture of the drug.

Salagen, Tablet, 5 mg (NDC 0228-2801-11)


Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) Syringes (NDC 0409-6637-14)


LYSINE, LEUCINE, PHENYLALANINE, VALINE, HISTIDINE, ISOLEUCINE, METHIONINE, THREONINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID, TYROSINE

ALANINE
ARGININE
ASPARTIC ACID
GLUTAMIC ACID
GLYCINE
HISTIDINE
ISOLEUCINE
LEUCINE
LYSINE ACETATE
METHIONINE
PHENYLALANINE
PROLINE
SERINE
THREONINE
TRYPTOPHAN
TYROSINE
VALINE

Clinisol 15% Sulfite Free In Plastic Container, Injection, 0.15 (NDC 0338-0502-03)


Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 43598-976-58)


Dobutamine Hydrochloride, Injection, 12.5 mg/1 mL (NDC 0409-2344-88)


Allocation to current contracted customers

Methylphenidate Hydrochloride, Tablet, Extended Release, 63 mg (NDC 13811-700-30)


Etomidate, Injection, 2 mg/1 mL (NDC 0143-9311-10)


Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-1312-36)


Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 42806-343-01)


Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 43066-007-10)


A business decision was made to discontinue. Distribution will end April 2026. The 200 mg/2 mL injection presentation (NDC 0002-3116-11) will remain.

Omvoh, Injection, 100 mg/1 mL (NDC 0002-8011-27)


Ultiva, Injection, 1 mg/1 mL (NDC 72078-034-01)


Dexamethasone Sodium Phosphate Injection

INTRA-ARTICULAR
INTRALESIONAL
INTRAMUSCULAR
INTRAVENOUS
SOFT TISSUE

Dermatology Endocrinology/Metabolism Gastroenterology Hematology Neurology Oncology Ophthalmology Other Pulmonary/Allergy Rheumatology

Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-421-30)


Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0406-5113-01)


Nebivolol Hydrochloride, Tablet, 20 mg (NDC 13668-356-30)


Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-25)


Distributed by Sagent Pharmaceuticals; Discontinuation of the manufacture of the drug

Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-04)


Solu-cortef, Injection, 100 mg/vial (NDC 0009-0011-04)


Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-27)


Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0527-0766-37)


Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-92)


Distributed by: Novadoz Pharmaceuticals LLC; Telephone: (855) 668-2369; customerservice@novadozpharma.com

Bumetanide, Injection, 0.25 mg/mL, 4mL (NDC 72205-101-01)


Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 57664-052-88)


Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0527-4661-37)


Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0480-3570-01)


Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 62175-310-37)


Morphine Sulfate, Injection, 10 mg/1 mL (NDC 0409-1893-01)


Anti-Inflammatory Agents, Non-Steroidal [CS]

Nonsteroidal Anti-inflammatory Drug [EPC]

Celecoxib, Capsule, 200 mg (NDC 0591-3984-05)


Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-03)


Epinephrine Bitartrate, Lidocaine Hydrochloride Injection

Next Delivery: July 2026; Estimated Recovery: September 2026; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay

Adrenergic alpha-Agonists [MoA]
Adrenergic beta-Agonists [MoA]

alpha-Adrenergic Agonist [EPC]
beta-Adrenergic Agonist [EPC]
Catecholamine [EPC]

Lidocaine Hydrochloride And Epinephrine, Injection, 300 mg/30 mL (1%; 1:100,000) (NDC 0409-3178-02)


Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-42)


Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-852-25)


Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-10)


Amlodipine Besylate; Benazepril Hydrochloride Capsule

Permanent discontinuation in the manufacturing of the drug

AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE

AMLODIPINE BESYLATE
BENAZEPRIL HYDROCHLORIDE

Lotrel, Capsule, 5 mg; 20 mg (NDC 0078-0406-05)


Fluphenazine Hydrochloride, Tablet, 5 mg (NDC 0832-6005-11)


Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0378-6855-77)


Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 50 mg/5mL (1%, 10 mg/1 mL) Syringes (NDC 0409-9137-05)


Tumor Necrosis Factor Receptor Blocking Activity [MoA]

Hyrimoz, Injection, 40 mg/.4 mL (NDC 61314-473-64)


Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 64850-555-01)


Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil Tablet

A business decision was made to discontinue manufacture of the product.

Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil, Tablet, 10 mg; 12.5 mg; 40 mg (NDC 13668-383-90)


Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.

Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-119-25)


Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-18)


Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 72516-011-01)


Next release not available at this time. Check wholesalers for inventory.

Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-50)


Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 55150-297-10)


Pravastatin Sodium, Tablet, 40 mg (NDC 0093-7202-10)


Anti-epileptic Agent [EPC]
Mood Stabilizer [EPC]

Organic Cation Transporter 2 Inhibitors [MoA]

Dihydrofolate Reductase Inhibitors [MoA]

Lamotrigine, Tablet, Extended Release, 250 mg (NDC 49884-604-11)


Nebivolol Hydrochloride, Tablet, 5 mg (NDC 13668-354-90)


Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-66)


Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 13811-706-10)


DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE

Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0185-0853-01)


Naropin, Injection, 2 mg/1 mL (NDC 63323-285-61)


Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.

Azacitidine, Injection, 100 mg/ Vial (NDC 0143-9606-01)


Cleocin Hydrochloride, Capsule, 300 mg (NDC 0009-0395-14)


Hydroxychloroquine Sulfate, Tablet, 200 mg (NDC 0093-2401-01)


Lamotrigine, Tablet, Extended Release, 300 mg (NDC 49884-605-11)


Methamphetamine Hydrochloride, Tablet, 5 mg (NDC 68308-115-01)


Naropin, Injection, 10 mg/1 mL (NDC 63323-288-21)


Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-10)


Everolimus, Tablet, 5 mg (NDC 0378-0007-85)


Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-27)


Limited Supply Available. Next Delivery: June 2026; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay

Morphine Sulfate, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-3815-12)


Discontinuation of the manufacture of the drug

Kinase Inhibitor [EPC]
mTOR Inhibitor Immunosuppressant [EPC]

Protein Kinase Inhibitors [MoA]
Cytochrome P450 3A4 Inhibitors [MoA]
Cytochrome P450 2D6 Inhibitors [MoA]
mTOR Inhibitors [MoA]

Everolimus, Tablet, 5 mg (NDC 0093-7767-24)


Cefotaxime Sodium, Powder, for Solution, 2 g (NDC 0143-9933-25)


ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-4179-05

ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, ASPARTIC ACID, GLUTAMIC ACID, GLYCINE, HISTIDINE, PROLINE, SERINE, TAURINE, AND TYROSINE

ALANINE
ARGININE
ASPARTIC ACID
GLUTAMIC ACID
GLYCINE
HISTIDINE
ISOLEUCINE
LEUCINE
LYSINE ACETATE
METHIONINE
PHENYLALANINE
PROLINE
SERINE
TAURINE
THREONINE
TRYPTOPHAN
TYROSINE
VALINE


Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 43547-602-10)


Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-718-11)


Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-95)


Discontinuation of the manufacture of the drug product

Klor-Con, Tablet, Extended Release, 750 mg (NDC 0245-5316-01)


Azacitidine, Injection, 100 mg (NDC 68001-313-56)


Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-6648-02)


Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-04)


Lamotrigine, Tablet, Extended Release, 100 mg (NDC 49884-563-11)


EPIDURAL INFILTRATION INTRACAUDAL PERINEURAL

Xylocaine, Injection, 20 mg/1 mL (NDC 63323-496-97)


Phenobarbital, Tablet, 97.2 mg (NDC 0603-5168-21)


Atropine Sulfate, Injection, (Adult) 0.5 mg/5 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4910-34)"


Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-167-10)


Next Delivery: May 2026; Estimated Recovery: June 2026; Shortage per Manufacturer: Manufacturing Delay

Midazolam Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-2596-05)


Meitheal Pharmaceuticals is distributor/labeler

Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 71288-728-32)


Not available. Long-term backorder for all NDCs. No estimated release date at this time.

Quinapril Hydrochloride, Tablet, 10 mg (NDC 43547-411-09)


Estimated recovery: TBD; check wholesalers for inventory

Carboplatin, Injection, 600 mg/60 mL (NDC 55150-386-01)


Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4246-01)


Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0527-4665-37)


Otrexup, Injection, 12.5 mg/.4 mL (NDC 82497-012-04)


Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-21)


Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 55150-304-25)


Glyburide (Micronized), Tablet, 6 mg (NDC 0093-8036-01)


Unbranded Insulin Aspart 3 mL FlexPen® will continue to be shipped to wholesalers while supplies last, up until the discontinuation dates. Full discontinuation will occur on December 31, 2025.

Insulin Aspart, Injection, 3 mL Insulin Aspart FlexPen® (NDC 73070-103-15)


Available. Distributed by Padagis US LLC

Methylphenidate, Film, Extended Release, 10 mg (NDC 0574-2410-65)


Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-41)


Quinapril Hydrochloride, Tablet, 40 mg (NDC 68180-554-09)

Requirements related to complying with good manufacturing practices


Hexatrione, Injection, 40 mg/2 mL (NDC 59137-570-01)


Amantadine Hydrochloride, Capsule, 100 mg (NDC 0832-1015-00)


Business decision. Products will not be available after November 14, 2025.

Ocaliva, Tablet, 5 mg (NDC 69516-005-30)


Ursodiol, Capsule, 300 mg (NDC 64380-844-06)


Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-168-30)


Solu-cortef, Injection, 1000 mg/vial (NDC 0009-0005-01)


Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-0121-25)


Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0185-2098-01)


A business decision was made to discontinue. Distribution will end April 2026. The 200 mg/2 mL injection presentation (NDC 0002-1442-11) will remain.

Omvoh, Injection, 100 mg/1 mL (NDC 0002-8870-27)


Naropin, Injection, 2 mg/1 mL (NDC 63323-285-65)


Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0264-2101-00)


Product in transit, expected to arrive last week of April 2026

Bumetanide, Injection, .25 mg/1 mL (NDC 25021-321-04)


On Allocation. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7922-02

Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-02)


Everolimus, Tablet, 2.5 mg (NDC 49884-119-91)


A business decision was made to discontinue manufacture of the product.

Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil, Tablet, 5 mg; 12.5 mg; 20 mg (NDC 13668-397-90)


Lidocaine Hydrochloride, Injection, 2%, USP (For Cardiac Use Only)  100 mg/5 mL (20 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4903-34)"


Oxaliplatin, Injection, 5 mg/1 mL (NDC 0781-3317-80)


Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 65862-162-90)


Atropine Sulfate, Injection, 0.1 mg/1 mL (NDC 16729-484-45)


See Related Information section below for customer service information

Marketed by Sandoz Inc.; Customer service: 800-525-8747

DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE

Dexmedetomidine Hydrochloride, Injection, 80 mcg/20 mL  (NDC 0781-3493-95)

Jiangsu Hengrui Pharmaceuticals Co., Ltd.


Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE

Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 64850-505-01)


Hydromorphone Hydrochloride, Injection, 4 mg/1 mL (NDC 63323-854-10)


Hyrimoz, Injection, 80 mg/.8 mL (NDC 61314-454-68)


On backorder. Recovery: TBD. Check wholesalers for inventory

Azacitidine, Injection, 100 mg/4 mL (NDC 55150-393-01)


Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 43547-605-10)


Alimta, Injection, 500 mg/20 mL (NDC 0002-7623-01)


Epinephrine, Injection, .1 mg/1 mL (NDC 0409-4933-01)


Lidocaine Hydrochloride In Plastic Container, Injection, 400 mg/20 mL (2%; 20 mg/mL) (NDC 0409-4277-01)


Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]

Liraglutide, Injection, 6 mg/1 mL (NDC 0480-7250-46)


Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0378-6859-77)


Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-87)


LEUCINE, LYSINE, ISOLEUCINE, VALINE, HISTIDINE, PHENYLALANINE, THREONINE, METHIONINE, TRYPTOPHAN, TYROSINE, N-ACETYL-TYROSINE, ARGININE, PROLINE, ALANINE, GLUTAMIC ACIDE, SERINE, GLYCINE, ASPARTIC ACID, TAURINE, CYSTEINE HYDROCHLORIDE

ALANINE
ARGININE
ASPARTIC ACID
CYSTEINE HYDROCHLORIDE
GLUTAMIC ACID
GLYCINE
HISTIDINE
ISOLEUCINE
LEUCINE
LYSINE ACETATE
METHIONINE
PHENYLALANINE
PROLINE
SERINE
TAURINE
THREONINE
TRYPTOPHAN
TYROSINE
VALINE

Premasol 10% Sulfite Free in VIAFLEX Plastic Container, Injection, 0.1 (NDC 0338-1130-06)


Vaprisol Dextrose In Plastic Container, Injection, 20 mg/100 mL (NDC 66220-160-10)


Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 71357-007-10)


Bupivacaine Hydrochloride, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-1159-01)


Clonazepam, Tablet, 1 mg (NDC 0093-3212-01)


Additional lots will be available in the May 2026 timeframe.  Product will be made available as it is released.

Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6030-01)


LIDOCAINE HYDROCHLORIDE ANHYDROUS AND DEXTROSE MONOHYDRATE

DEXTROSE MONOHYDRATE
LIDOCAINE HYDROCHLORIDE ANHYDROUS

Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-20)


Lidocaine Hydrochloride, Injection, 300 mg/30 mL (1%; 10 mg/mL) (NDC 0409-4279-02)


Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 57664-047-88)


Lots are being manufactured to meet demand

Ativan, Injection, 2 mg/1 mL (NDC 0641-6001-25)


Methotrexate Sodium, Injection, 25 mg/1 mL (NDC 63323-123-10)


Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-196-99)


Inventory available 2 to 6 weeks as per current demand. Next supply: week of 2/23/2026

Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 70121-1388-8)


Discontinuation of the manufacture of the drug.

Fluphenazine Hydrochloride, Tablet, 10 mg (NDC 0832-6006-11)


Furosemide, Injection, 10 mg/1 mL (NDC 16729-502-43)


Furosemide, Injection, 10 mg/1 mL (NDC 36000-283-25)


Discontinuation of the manufacture of the drug

Morphine Sulfate, Injection, 8 mg/1 mL (NDC 0409-1892-01)


Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-75)


Dopamine Hydrochloride in Dextrose 5% in plastic container, Injection, 800 mg/500 mL (1,600 mcg/mL) (NDC 0409-7809-24)


Furosemide, Injection, 10 mg/1 mL (NDC 71288-203-05)


Methylphenidate Hydrochloride Tablet, Extended Release

Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-30)


Omeprazole, Delayed Release Capsule, 10 mg (NDC 0781-2859-01)


Next Delivery and Estimated Recovery: TBD

Accupril, Tablet, 20 mg (NDC 0071-0532-23)


845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com

Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 62135-667-90)


Sterile Water, Irrigant, 100 mL/100 mL (NDC 0338-0004-02)


Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-109-10)


Precedex, Injection, 80 mcg/20 mL (4 mcg/mL) (NDC 0409-3301-10)


Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil, Tablet, 5 mg; 12.5 mg; 40 mg (NDC 13668-386-30)


Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-10)


Hydromorphone Hydrochloride, Injection, 1 mg/1 mL Syringes (NDC 0409-1283-31)


Insulin Aspart Protamine and Insulin Aspart Mix 70/30 Injectable Suspension

Unbranded Insulin aspart protamine and insulin aspart FlexPen® will continue to be shipped to wholesalers while supplies last, up until the discontinuation dates. Full discontinuation will occur on December 31, 2025.

INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30

Insulin Aspart Protamine and Insulin Aspart Mix 70/30, Injectable Suspension, 3 mL vial Insulin aspart protamine and insulin aspart Mix 70/30 FlexPen® (NDC 73070-203-15)


800-JANSSEN (1-800-526-7736) Monday through Friday from 9:00 AM to 8:00 PM ET

Concerta, Tablet, Extended Release, 36 mg (NDC 50458-586-01)


A business decision was made to discontinue manufacture of the drug.

Oxaliplatin, Injection, 5 mg/mL (NDC 63323-750-10)


Increased Hematopoietic Stem Cell Mobilization [PE]

Plerixafor, Injection, 24 mg per 1.2 mL (20 mg per mL) (NDC 65219-284-12)


Inventory available in vial presentations.

Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6024-10)


Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 66794-228-41)


Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-456-60)


INTRALESIONAL
INTRAMUSCULAR
INTRASYNOVIAL
SOFT TISSUE

Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-52)


Next release May 2026. Check wholesalers for inventory.

Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-12)


Omeprazole, Delayed Release Capsule, 40 mg (NDC 0781-2234-01)


Quinapril Hydrochloride, Tablet, 40 mg (NDC 65862-620-90)


Diuril, Oral Suspension, 250 mg/5mL (NDC 65649-311-12)

Salix Pharmaceuticals, a division of Bausch Health US, LLC


844-842-8672 and email: CustomerService-US@alvogen.com

Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 47781-563-01)


Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 51754-5011-4)


(866) 850-2876 OR CustomerService@AurobindoUSA.com

Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 13107-074-01)


Limited Supply Available. Next Delivery: May 2026; Estimated Recovery: June 2026

Midazolam Hydrochloride Preservative Free, Injection, 5 mg/5 mL (1 mg/mL) (NDC 0409-2305-05)


Tamiflu, Capsule, 30 mg (NDC 0004-0802-85)


Additional lots will be available.  Product will be made available as it is released.

Remifentanil Hydrochloride, Injection, 5 mg per vial (NDC 0143-9393-10)


Sterile Water, Injection, 1000 mL/1000 mL (NDC 63323-178-76)


Azithromycin, Injection, 500 mg Single Dose ADD-Vantage® Glass Vial (NDC 0409-0144-11)


Dexmedetomidine Hydrochloride, Injection, 4 mcg/mL, 100 mL (NDC 70121-1389-1)


Etomidate, Injection, 2 mg/1 mL (NDC 67457-902-10)


Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 55150-165-05)


Metronidazole In Plastic Container, Injection, 500 mg/100 mL (NDC 47335-993-01)


Naltrexone Hydrochloride, Tablet, 50 mg (NDC 51224-206-30)


Phenobarbital, Tablet, 16.2 mg (NDC 0603-5165-21)


Next Delivery and Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay

Demerol, Injection, 25 mg/1 mL (NDC 0409-1176-30)


To be discontinued in approximately November 2026.

Neurokinin 1 Antagonists [MoA]
Cytochrome P450 3A4 Inhibitors [MoA]
Cytochrome P450 2C9 Inducers [MoA]
Cytochrome P450 3A4 Inducers [MoA]

Substance P/Neurokinin-1 Receptor Antagonist [EPC]

Emend, Oral Powder for Suspension, 125 mg (NDC 0006-3066-03)


Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) (NDC 0409-6625-14)


Discontinuation of the manufacturing of the capsule presentation. 100 mg Tablet NDC 0069-0486-03 will continue to be manufactured.

Kinase Inhibitors [MoA]
Cytochrome P450 3A Inhibitors [MoA]

Ibrance, Capsule, 100 mg (NDC 0069-0188-21)


Sodium Chloride 0.9%, Injection, 250 mL  ADD-Vantage® Flexible Container (NDC 0409-7101-02)


Lisdexamfetamine Dimesylate Tablet, Chewable

Vyvanse, Tablet, Chewable, 60 mg (NDC 59417-120-01)


Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-01)


Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-00)


Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection

6, 7 & 8 month expiry available upon request. Check wholesaler for inventory

BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE

BUPIVACAINE HYDROCHLORIDE
EPINEPHRINE BITARTRATE

Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-468-37)


Glyburide (Micronized), Tablet, 1.5 mg (NDC 0093-8034-01)


Lidocaine Hydrochloride And Dextrose, Injection, 4 mg/1 mL (NDC 0338-0409-03)


Estimated recovery: TBD; Shortage per Manufacturer: Manufacturing Delay

Demerol, Injection, 75 mg/1 mL (NDC 0409-1179-30)


Permanent discontinuation in the manufacturing of the drug

Metoprolol Tartrate, Tablet, 50 mg (NDC 65862-063-01)


Inventory available at Cardinal Health, McKesson, Cencora (FKA Amerisource Bergen). Product (LIDOCAINE HCL 2% 10X5ML)  is Preservative free.

Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 83090-005-10)


DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE


Rifampin, Capsule, 150 mg (NDC 68180-658-06)


Next release not available at this time. Check wholesaler for inventory.

Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-065-05)


Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 25 mg/10 mL (2.5 mg/mL 1:200,000) (NDC 0409-1746-10)


Precedex, Injection, 1000 mcg/250 mL Glass Bottle NovaPlus (NDC 0409-2815-01)


Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 64850-500-01)


LEUCINE, PHENYLALANINE, LYSINE HYDROCHLORIDE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, TYROSINE, SERINE

ALANINE
ARGININE
GLYCINE
HISTIDINE
ISOLEUCINE
LEUCINE
LYSINE HYDROCHLORIDE
METHIONINE
PHENYLALANINE
PROLINE
SERINE
THREONINE
TRYPTOPHAN
TYROSINE
VALINE


Clonazepam, Tablet, .5 mg (NDC 72888-152-00)


Midazolam Hydrochloride Preservative Free, Injection, 5 mg/mL (5 mg/mL) (NDC 0409-2308-01)


Next release April 2026. Check wholesalers for inventory.

Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-723-03)


Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-34)


VALINE, LYSINE, HISTIDINE, ISOLEUCINE, LEUCINE, PHENYLALANINE, THREONINE, METHIONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE


Guanfacine Hydrochloride Tablet, Extended Release

Guanfacine Hydrochloride, Tablet, Extended Release, 3 mg (NDC 0228-2853-11)


Dextrose Monohydrate 5%, Injection, 5 g/100 mL (NDC 0264-7510-10)


Injection, 0.25 mg/ 0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-1805-01)


Furosemide, Oral Solution, 10 mg/1 mL (NDC 0054-3294-50)

Shortage of an inactive ingredient component


Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 70010-115-01)


Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0378-6854-77)


Discontinuation of the manufacture of the drug

Otrexup, Injection, 17.5 mg/.4 mL (NDC 82497-017-04)


Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 57664-607-88)


Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 65162-023-09)


Rifadin, Injection, 600 mg/10 mL (NDC 0068-0597-01)


Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 72516-013-01)


Fentanyl Citrate, Injection, 1000 mcg/20 mL (50 ug/1 mL) (NDC 0409-9094-31)


Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0305-1)

EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.)


Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-10)


Next Delivery: May 2026; Estimated Recovery: June 2026; Shortage per Manufacturer: Manufacturing Delay

Marcaine, Injection, Marcaine 125 mg/50 mL (2.5 mg/mL) (NDC 0409-1587-50)


Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-02)


Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9251-10)


Potassium Chloride Capsule, Extended Release

Potassium Chloride, Capsule, Extended Release, 600 mg (NDC 62037-559-05)


Bupivacaine Hydrochloride, Injection, 125 mg/50 mL (2.5 mg/mL) (NDC 0409-1160-01)


Discontinuation of the manufacture of the drug product

Finasteride, Tablet, 5 mg (NDC 0093-7355-05)


Mitigo, Injection, 200 mg/20 mL (NDC 66794-160-02)


Vyvanse, Tablet, Chewable, 50 mg (NDC 59417-119-01)


Meitheal Pharmaceuticals is distributor/labeler

Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-725-32)


Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-44)


Additional lots are scheduled to be manufactured.  Product will be made available as it is released.

Lidocaine Hydrochloride, Preservative Free, Injection, 20 mg/1 mL (NDC 0143-9594-25)


Omeprazole, Delayed Release Capsule, 40 mg (NDC 0781-2234-10)


Allocated to Contracted Customers Only. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7139-09

Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0990-7139-09)


Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 42023-186-20)


Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 250 mg/250mL (100 mg/mL) (NDC 0409-2346-32)


Lamotrigine, Tablet, Extended Release, 50 mg (NDC 49884-562-11)


Metoprolol Tartrate, Tablet, 50 mg (NDC 65862-063-99)


Quinapril Hydrochloride, Tablet, 5 mg (NDC 62135-484-60)


Discontinuation of the manufacture of the drug.

Peroxisome Proliferator Receptor alpha Agonist [EPC]

Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]


Corlanor, Tablet, eq. 7.5 mg base (NDC 55513-810-60)


Euthyrox, Tablet, 125 ug (NDC 72305-125-30)


INTRA-ARTERIAL INTRAMUSCULAR INTRATHECAL INTRAVENOUS

Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 16729-277-30)


Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 57664-609-88)


Nebivolol Hydrochloride, Tablet, 10 mg (NDC 13668-355-01)


Rifampin, Capsule, 300 mg (NDC 42806-799-60)


Sodium Chloride, Injection, 9 g/1000 mL (NDC 84898-911-02)


Midazolam Hydrochloride, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-2587-05)


Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-85)


Acetaminophen; Oxycodone Hydrochloride Tablet

Acetaminophen; Oxycodone Hydrochloride, Tablet, 325 mg; 2.5 mg (NDC 63481-627-70)


Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 76045-107-10)


Methotrexate Sodium, Injection, 50 mg/2 mL (25 mg/mL) (NDC 61703-350-38)


Analgesia/Addiction Gastroenterology Other Pulmonary/Allergy

Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 39822-5525-3)


Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 57664-608-88)


Pemetrexed Ditromethamine, Injection, 500 mg Single Dose Vial (NDC 0409-1061-01)


Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 44567-602-24)


Potassium Chloride, Capsule, Extended Release, 750 mg (NDC 62037-560-90)


Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 0409-4900-14)


Product is expected to be available through February 2027.

Rozerem, Tablet, 8 mg (NDC 64764-805-10)


Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 0781-3290-09)


Azacitidine, Injection, 100 mg/30 mL (NDC 63323-771-39)


Clindamycin Phosphate, Injection, 600 mg/50 mL (NDC 0338-3612-50)


Clonazepam, Tablet, 1 mg (NDC 72888-153-05)


Dexamethasone Sodium Phosphate Injection

Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-423-12)


Ativan, Injection, 2 mg/1 mL (NDC 0641-6000-10)


Atropine Sulfate, Injection, .4 mg/1 mL (NDC 0517-1004-25)


Clonazepam, Tablet, .5 mg (NDC 0093-0832-05)


Diltiazem Hydrochloride, Injection, 100 mg Single Dose ADD-Vantage® Glass Vial (NDC 0409-4350-03)


Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6046-10)


Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0527-4666-37)


Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 55150-226-10)


EPIDURAL INTRACAUDAL PERINEURAL INFILTRATION

Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-37)


Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (NDC 72205-134-91)


Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 42023-146-25)


Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-172-30)


Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-464-50)


Methotrexate, Preservative Free, Injection, 25 mg/1 mL (NDC 0143-9519-10)


Naltrexone Hydrochloride, Tablet, 50 mg (NDC 47335-326-18)


Nebivolol Hydrochloride, Tablet, 10 mg (NDC 13668-355-90)


Quinapril Hydrochloride, Tablet, 5 mg (NDC 65862-617-90)


Amantadine Hydrochloride, Capsule, 100 mg (NDC 0832-1015-50)


Ethinyl Estradiol; Ethinyl Diacetate Tablet


Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE

Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 0527-0763-37)


DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE

Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0406-8893-01)


Naropin, Injection, 2 mg/1 mL (NDC 63323-285-10)


Distributed by Sagent Pharmaceuticals: 1-866-625-1618, Discontinued product

Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-04)


Marcaine, Injection, Marcaine 25 mg/10 mL (2.5 mg/mL) (NDC 0409-1559-10)


On backorder. Recovery: TBD. Check wholesalers for inventory

Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-250-50)


Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 67457-925-10)


Dextrose Monohydrate 70%, Injection, 70 g/100 mL (NDC 0264-7387-50)


Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0338-0072-25)


Euthyrox, Tablet, 50 ug (NDC 72305-050-90)


Naltrexone Hydrochloride, Tablet, 50 mg (NDC 47335-326-08)


Vigpoder, Oral Solution, 50 mg/1 mL (NDC 80789-117-50)


Klonopin, Tablet, .5 mg (NDC 61269-605-10)


Eszopiclone, Tablet, 3 mg (NDC 0093-5539-01)


Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 42858-167-01)


Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-10)


A business decision was made to discontinue manufacture of the drug.

Pentamidine Isethionate, Injection, 300 mg/3 mL (NDC 39822-3050-2)


Norditropin, Injection, 30 mg/3 mL (NDC 0169-7703-21)


Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 0527-0764-37)


Allocation to current contracted customers

Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 13811-708-10)


Hyrimoz, Injection, Kit (NDC 61314-517-36)


Pravastatin Sodium, Tablet, 80 mg (NDC 0480-7270-98)


Rifampin, Capsule, 300 mg (NDC 42806-799-05)


Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 66794-229-41)


Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 0781-3289-09)


Methamphetamine Hydrochloride, Tablet, 5 mg (NDC 0054-0389-25)


732-382-6085 Monday to Friday 9 am to 3:45 pm

Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 11534-191-01)


Concerta, Tablet, Extended Release, 27 mg (NDC 50458-588-01)


Desowen, Lotion, .5 mg/1 mL (NDC 0472-0803-02)


Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil Tablet

A business decision was made to discontinue manufacture of the product.

Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil, Tablet, 5 mg; 25 mg; 40 mg (NDC 13668-385-05)


Additional lots will be available.  Product will be made available as it is released.

Remifentanil Hydrochloride, Injection, 1 mg per vial (NDC 0143-9391-10)


A business decision was made to discontinue manufacture of the drug

Calcitriol, Capsule, .25 ug (NDC 0093-7352-01)


Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-150-05)


Lyumjev, Injection, U-100 Tempo Pen (NDC 0002-8235-05)


Euthyrox, Tablet, 112 ug (NDC 72305-112-90)


Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-254-10)


Xylocaine, Injection, 5 mg/1 mL (NDC 63323-491-57)


Methotrexate Sodium, Injection, 50 mg/2 mL  (25 mg/mL) (NDC 61703-350-10)


Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-1403-10)


Sodium Bicarbonate, Injection, 75 mg/1 mL (NDC 0409-4916-14)


Fentanyl Citrate, Injection, 2500 mcg/50 mL (50 ug/1 mL) (NDC 0409-9094-61)


Distributed by Avenacy; Contact information: 877-283-6229

Furosemide, Injection, 10 mg/1 mL; 2mL vial (NDC 83634-302-02)


INTRA-ARTICULAR
INTRALESIONAL
INTRAMUSCULAR
INTRASYNOVIAL
SOFT TISSUE

Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-05)


Not available. Long-term backorder for all NDCs. No estimated release date at this time.

Quinapril Hydrochloride, Tablet, 5 mg (NDC 43547-410-09)


Discontinuation of the manufacture of the drug

Rifadin, Injection, 600 mg/10 mL (NDC 0068-0597-01)


Angiotensin 2 Receptor Antagonists [MoA]

Valsartan, Tablet, 160 mg (NDC 0378-5814-77)


ALBUTEROL SULFATE INHALATION SOLUTION, 0.5%

Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 76204-027-01)


Estimated recovery: TBD; check wholesalers for inventory

Carboplatin, Injection, 450 mg/45 mL (NDC 55150-335-01)


Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4244-01)


Clonazepam, Tablet, 1 mg (NDC 43547-407-11)


Dextrose Monohydrate 50%, Injection, 50% Dextrose Injection 0.5 g/mL; ABBOJECT® Glass Syringe (NDC 0409-4902-34)


Doxycycline Hyclate, Tablet, 100 mg (NDC 0591-5553-50)


Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0431-03)


Reyataz, Oral Powder, 50 mg (NDC 0003-3638-10)


Verapamil Hydrochloride, Injection, 2.5 mg/1 mL (NDC 0409-9633-05)


Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-38)


DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS,CII

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS, 10 MG,CLL

Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 47781-176-01)


Vancomycin Hydrochloride, Injection, 1 g Single Dose ADD-Vantage® Glass Vial (NDC 0409-6535-01)


Additional product will be made available as it is released.

Etomidate, Injection, 2 mg/1 mL (NDC 0143-9506-10)


DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS, 20 MG,CLL

Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 47781-179-01)


Naltrexone Hydrochloride, Tablet, 50 mg (NDC 47335-326-83)


Limited Supply Available. Next Delivery: May 2026; Estimated Recovery: September 2026

Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) (NDC 61703-339-18)


Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 42571-132-52)


Desmopressin Acetate (needs No Refrigeration), Spray, 10 ug (NDC 60505-0815-0)


Icosapent Ethyl, Capsule, 1 g (NDC 61474-9711-1)


Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6042-25)


Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-163-30)


Next Delivery and Estimated Recovery: TBD


Everolimus, Tablet, 10 mg (NDC 49884-128-91)


Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-164-02)


Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0406-5116-01)


Atropine Sulfate, Injection, 0.25 mg/5 mL (0.05 mg/mL) Syringes (NDC 0409-9630-05)


Next Delivery: May 2026; Estimated Recovery: June 2026; Shortage per Manufacturer: Manufacturing Delay

Lidocaine Hydrochloride In Plastic Container, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4275-01)


Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0527-4664-37)


Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-725-10)


Exelderm, Solution, 1.0% 5 mL (NDC 69489-721-05)


Clonazepam, Tablet, 2 mg (NDC 59651-724-01)


Epinephrine Bitartrate, Lidocaine Hydrochloride Injection

Limited Supply Available. Next Delivery and Estimated Recovery: June 2026; Shortage per Manufacturer: Manufacturing Delay

Lidocaine Hydrochloride And Epinephrine, Injection, 450 mg/30 mL (1.5%; 1:200,000) (NDC 0409-3181-01)


Euthyrox, Tablet, 50 ug (NDC 72305-050-30)


Hyrimoz, Injection, Kit (NDC 61314-531-64)


Potassium Chloride Tablet, Extended Release

Potassium Chloride, Tablet, Extended Release, 20 meq (NDC 62037-720-01)


Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection

Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay

BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE

Bupivacaine Hydrochloride and Epinephrine, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-9045-17)


Lidocaine Hydrochloride Preservative Free, Injection, 300 mg/20 mL (1.5%; 15 mg/mL) (NDC 0409-4776-01)


Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-159-74)


Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0406-8894-01)


Discontinuation of the manufacture of the drug product

Klor-Con, Tablet, Extended Release, 600 mg (NDC 0245-5315-11)


Limited supply; Check wholesalers for inventory; Marketed by Baxter

Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 43066-023-10)


Allocated to Contracted Customers Only. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-6139-03

Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0990-6139-03)


Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-170-30)


ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-4178-03

ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, ASPARTIC ACID, GLUTAMIC ACID, GLYCINE, HISTIDINE, PROLINE, SERINE, TAURINE, AND TYROSINE


Amidate, Injection, 2 mg/mL (NDC 0409-6695-02)


Estimated recovery: TBD; Shortage per Manufacturer: Manufacturing Delay

Demerol, Injection, 50 mg/1 mL (NDC 0409-1418-01)


Permanent discontinuation in the manufacturing of the drug

Metoprolol Tartrate, Tablet, 100 mg (NDC 65862-064-01)


Additional lots are scheduled to be manufactured. Product will be made available as it is released.

Morphine Sulfate, Injection, 10 mg/1 mL (NDC 0641-6127-25)


Pegasys availability will become more limited through Q4 2025. Product replenishment is expected sometime in 2026 and before May 31, 2026.

Pegasys, Injection, 180 ug/1 mL (NDC 82154-0449-1)


Abrilada, Injection, Kit (NDC 0025-0325-01)


Bupivacaine Hydrochloride, Injection, 250 mg/50 mL (5 mg/mL) (NDC 0409-1163-01)


Wholesaler & Distributor through Marketing partner (Apotex Inc.)

Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-1)


Cleocin Phosphate, Injection, 300 mg/2 mL (150 mg/mL) (NDC 0009-3051-02)


Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-50)


Atropine Sulfate, Injection, 1 mg/1 mL (NDC 16729-526-08)


Discontinuation of the manufacture of the drug

Everolimus, Tablet, 2.5 mg (NDC 0093-7766-24)


Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.

Lidocaine Hydrochloride, Preservative Free, Injection, 10 mg/1 mL (NDC 0143-9595-25)


Clonazepam, Tablet, 2 mg (NDC 43547-408-10)


Discontinuation of the manufacture of the drug upon exhausted supply/stop sale in December 2025.

Vyndaqel, Capsule, 20 mg soft gelatin capsules; blister card (120 total capsules) (NDC 0069-1975-40)


Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.

Etomidate, Injection, 2 mg/1 mL (NDC 72266-147-10)


Homatropine Methylbromide and Hydrocodone Bitartrate Syrup

HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE

HOMATROPINE METHYLBROMIDE
HYDROCODONE BITARTRATE


Methylphenidate Hydrochloride Tablet, Extended Release

Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 62037-727-01)


Azacitidine, Injection, 100 mg (NDC 16729-306-10)


Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 0409-1165-01)


On Allocation. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7922-61

Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-61)


Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-239-93)


Unbranded Insulin Degludec 10 mL vial will continue to be shipped to wholesalers while supplies last, up until the discontinuation dates. Full discontinuation will occur on December 31, 2025.

Insulin Degludec, Injection, 10 mL Insulin Degludec vial (NDC 73070-400-11)


Actidose Aqua, Oral Suspension, 208 mg/1 mL (NDC 0574-0521-76)


Clonazepam, Tablet, 2 mg (NDC 72888-154-01)


Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-02)


Naropin, Injection, 5 mg/1 mL (NDC 63323-286-31)


Lidocaine Hydrochloride Preservative Free, Injection, 50 mg/5 mL (1%; 10 mg/mL) (NDC 0409-4713-02)


Ampicillin Sodium, Injection, 1 g (NDC 0781-9412-92)


Nebivolol Hydrochloride, Tablet, 5 mg (NDC 13668-354-30)


Singulair, Tablet, Chewable, 4 mg (NDC 78206-170-01)


A business decision was made to discontinue manufacture of the drug.

Valsartan, Tablet, 40 mg (NDC 0378-5807-93)


Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-3410-50)


Clonazepam, Tablet, 1 mg (NDC 16729-137-00)


Etomidate, Injection, 2 mg/1 mL (NDC 72572-161-10)


Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-02)


Clonazepam, Tablet, 2 mg (NDC 43547-408-50)


Potassium Chloride Capsule, Extended Release

Potassium Chloride, Capsule, Extended Release, 750 mg (NDC 62037-560-01)


Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 62332-599-25)


Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-05)


A business decision was made to discontinue manufacture of the product

Dietary Cholesterol Absorption Inhibitor [EPC]

Ezetimibe, Tablet, 10 mg (NDC 0591-3713-19)


Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 70010-116-01)


Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-03)


Inventory available at Cardinal Health, McKesson, Cencora (FKA Amerisource Bergen). Product (LIDOCAINE HCL 2% 10X10ML) is Preservative free.

Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 83090-006-10)


Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]

Breast Cancer Resistance Protein Inhibitors [MoA]


Discontinuation of the manufacture of the drug; Distributed by Sandoz Inc.

Fondaparinux Sodium, Injection, 7.5 mg/.6 mL (NDC 0781-3465-95)


Product expected to be available until August 2025.

Isoniazid, Tablet, 300 mg (NDC 64950-217-03)


INTRALESIONAL
INTRAMUSCULAR
INTRASYNOVIAL
SOFT TISSUE
INTRA-ARTICULAR

Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-23)


Quinapril Hydrochloride, Tablet, 20 mg (NDC 62135-486-90)


Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0555-0775-02)


Allopurinol, Tablet, 100 mg (NDC 0591-5543-01)


Dexamethasone Sodium Phosphate Injection

Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 70069-021-25)


This product discontinuation is a business-related decision. The anticipated date that Prasco will cease distribution of the product is approximately March 16, 2026.

Serotonin 1b Receptor Agonists [MoA]
Serotonin 1d Receptor Agonists [MoA]

Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]

Imitrex, Nasal Spray, 20 mg/100 uL (NDC 66993-082-69)


Clonazepam, Tablet, .5 mg (NDC 43547-406-50)


Gemcitabine Hydrochloride, Injection, 2 g/52.6 mL (38 mg/mL), sterile solution in a single-dose glass vial NovaPlus (NDC 0409-0182-25)


Actidose Aqua, Oral Suspension, 208 mg/1 mL (NDC 0574-0521-25)


A business decision was made to discontinue manufacture of the 50 mg and 100 mg tablets. Distribution will end on May 31, 2026.


Lidocaine Hydrochloride, Injection, 1%, USP (For Cardiac Use Only) 50 mg/5 mL (10 mg/mL) LifeShield™ ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4904-34)"


Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-10)


Phenobarbital, Tablet, 32.4 mg (NDC 0603-5166-32)


Potassium Chloride, Tablet, Extended Release, 20 meq (NDC 62037-720-10)


Zanosar, Powder, For Solution, 100 mg/1 mL (NDC 0703-4636-01)


Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4239-01)


Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 62175-311-37)


Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 57664-606-88)


Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 11534-195-01)


Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 0555-0777-02)


BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE

Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 125 mg/50 mL (2.5 mg/mL 1:200,000) (NDC 0409-1752-50)


Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE

Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0527-0760-37)


Otrexup, Injection, 20 mg/.4 mL (NDC 82497-020-04)


Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay

Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-1134-05)


Sterile Water, Irrigant, 100 mL/100 mL (NDC 0338-0004-03)


Clonazepam, Tablet, 2 mg (NDC 59651-724-05)


Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0431-03)


Euthyrox, Tablet, 200 ug (NDC 72305-200-30)


Dopamine Hydrochloride, Injection, 200 mg/5mL (40 mg/1 mL) (NDC 0409-5820-01)


Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 65862-161-90)


Benztropine Mesylate, Injection, 1 mg/1 mL (NDC 63323-970-02)


Euthyrox, Tablet, 75 ug (NDC 72305-075-30)


On Allocation. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7930-02

Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-02)


Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/100 mL (NDC 0338-1077-02)


To be discontinued in approximately Q4 2026.

Primaxin, Injection, 500mg (NDC 0006-3516-59)


Euthyrox, Tablet, 25 ug (NDC 72305-025-30)


On backorder. Recovery: TBD. Check wholesalers for inventory

Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-256-50)


Next Delivery and Estimated Recovery: TBD

Accupril, Tablet, 40 mg (NDC 0071-0535-23)


Check wholesalers for inventory; Marketed by Armas Pharmaceuticals, Inc. 908-803-2586

Etomidate, Injection, 2 mg/mL (NDC 72485-508-10)


Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3675-01)


Product temporarily on backorder.  Additional lots will be available in the May 2026 timeframe.

Morphine Sulfate, Injection, 8 mg/1 mL (NDC 0641-6126-25)


Technetium TC-99M Pyrophosphate Kit Injection

KIT FOR THE PREPARATION OF TECHNETIUM TC99M PYROPHOSPHATE

CIS-PYRO, Injection, 12 mg/10 mL (NDC 45567-0060-2)


Next release May 2026. Check wholesalers for inventory.

Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-10)


Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 42858-163-01)


Discontinuation of the manufacture of the drug

Noxafil, Injection, 18 mg/1 mL (NDC 0085-4331-01)


Marketed by Piramal Critical Care Inc.: 800-414-1901

Dexmedetomidine Hydrochloride, Injection, 200 ug/2 mL (NDC 66794-230-42)


Fluticasone Propionate; Salmeterol Xinafoate Powder

FLUTICASONE PROPIONATE
SALMETEROL XINAFOATE

AirDuo RespiClick, Powder, 232 ug; 14 ug (NDC 59310-822-06)


DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE

Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0406-8891-01)


Abelcet, Injection, 5 mg/1 mL; 3.4 mg/1 mL; 1.5 mg/1 mL (NDC 57665-101-41)


Estimated recovery: end of August 2026; Distributed by BPI Labs, LLC

Carboplatin, Injection, 150mg/15mL (NDC 54288-165-01)


Clonazepam, Tablet, 2 mg (NDC 0093-3213-01)


LYSINE ACETATE, LEUCINE, PHENYLALANINE, VALINE, ISOLEUCINE, METHIONINE, THREONINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, HISTIDINE, PROLINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID, AND TYROSINE

Plenamine, Injection, 0.15 (NDC 0264-4500-00)


Epinephrine Bitartrate, Lidocaine Hydrochloride Injection

Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-17)


Hydrocortisone Sodium Succinate Injection

Dermatology Endocrinology/Metabolism Gastroenterology Hematology Neurology Oncology Ophthalmology Pediatric Pulmonary/Allergy Renal Rheumatology

Hydrocortisone Sodium Succinate, Injection, 100 mg/ Vial (NDC 69097-004-67)


Allocated to Contracted Customers Only. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-6139-22

Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0990-6139-22)


Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-88)


Discontinuation of the manufacture of the drug.
Supply expected to exhaust September 2025

Trecator, Tablet, 250 mg (NDC 0008-4117-01)


Neurocrine is discontinuing only the 25 mg soft gel capsule dose strength (NDC 70370-5025-01). The 50mg and 100mg soft gel capsule dose strength (NDC 70370-5050-1 and 70370-5100-1), and 50 mg/mL oral solution will continue to be marketed (NDC 70370-5250-1).

Corticotropin-releasing Factor Type 1 Receptor Antagonist [EPC]

Corticotropin-releasing Factor Type 1 Receptor Antagonists [MoA]

Crenessity, Capsule, 25 mg (NDC 70370-5025-1)


Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 44567-601-04)


Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 11534-194-01)


A business decision was made to discontinue manufacture of the drug.

Oxaliplatin, Injection, 5 mg/mL (NDC 63323-750-20)


Pemetrexed Disodium, Injection, 100 mg/4 mL (NDC 0781-3518-76)


Precedex, Injection, 1000 mcg/250 mL (NDC 0409-7875-12)


Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0406-5111-01)


Nebivolol Hydrochloride, Tablet, 20 mg (NDC 13668-356-01)


Lidocaine Hydrochloride, Injection, 200 mg/10 mL (2%; 20 mg/mL) (NDC 0409-4282-02)


Omeprazole, Delayed Release Capsule, 20 mg (NDC 0781-2868-10)


Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 67457-420-10)


Docetaxel, Injection, 20 mg/2 mL (10 mg/mL) Single Dose ONCO-TAIN™ Glass Fliptop Vial Novaplus®  (NDC 0409-2026-01)


Additional lots will be available in the August 2026 timeframe.  Product will be made available as it is released.

Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9254-25)


Gemcitabine Hydrochloride, Injection, 1 g/26.3 mL (38 mg/mL), sterile solution in a single-dose glass vial  NovaPlus (NDC 0409-0181-25)


Hydromorphone Hydrochloride, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-2634-05)


A business decision was made to discontinue manufacture of the 50 mg and 100 mg tablets. Distribution will end on May 31, 2026.


Everolimus, Tablet, 7.5 mg (NDC 0093-7768-24)


Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 73293-0001-2)


Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 65162-028-09)


Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 0143-9872-10)


Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-05)


DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE

Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 43066-557-12)


EPINEPHRINE BITARTRATE
LIDOCAINE HYDROCHLORIDE ANHYDROUS

Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-57)


Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 13107-072-01)


Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0378-6858-77)


Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 47781-565-01)


Morphine Sulfate, Injection, 4 mg/1 mL Syringes (NDC 0409-1891-01)


The NDC codes are being discontinued, to be replaced with NDC labeler code #46163.

DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE

DELFLEX® w/Dextrose, Solution, 1.5% Low Mg/Low Ca 2.5L/3L, 5/cs (NDC 49230-206-94)


Rifampin, Injection, 600 mg/10 mL (NDC 67457-445-60)


Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-02)


Bupivacaine Hydrochloride, Injection, 225 mg/30 mL (7.5 mg/mL) (NDC 0409-1165-02)


Next Delivery and Estimated Recovery: June 2026

Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) (NDC 61703-600-05)


Euthyrox, Tablet, 137 ug (NDC 72305-137-90)


Vyvanse, Capsule, 50 mg (NDC 59417-105-10)


Morphine Sulfate, Injection, 10 mg/1 mL Syringes (NDC 0409-1893-01)


Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 0409-5534-14)


Next Delivery and Estimated Recovery: June 2026; Shortage per Manufacturer: Manufacturing Delay

Bupivacaine Hydrochloride, Injection, Bupivacaine Spinal 15 mg/2 mL (7.5 mg/mL in 8.25% dextrose) (NDC 0409-3613-01)


Discontinuation of the manufacture of the drug product

Finasteride, Tablet, 5 mg (NDC 0093-7355-98)


Euthyrox, Tablet, 150 ug (NDC 72305-150-30)


Lidocaine Hydrochloride In Plastic Container, Injection, 1,000 mg/50 mL (2%; 20 mg/mL) (NDC 0409-4277-02)


Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-42)


Next Delivery: May 2026; Estimated Recovery: June 2026; Shortage per Manufacturer: Manufacturing Delay

Marcaine, Injection, Marcaine 75 mg/10 mL (7.5 mg/mL) (NDC 0409-1582-10)


Sporanox, Capsule, 100 mg (NDC 10147-1700-3)


ENDOTRACHEAL INTRAMEDULLARY INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS

Atropine Sulfate, Injection, 0.4 mg/1 mL (NDC 0641-6251-10)


Additional lots are scheduled to be manufactured.  Product will be made available as it is released.

Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6060-10)


Everolimus, Tablet, 7.5 mg (NDC 49884-127-91)


Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0054-0375-25)


Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0480-3569-01)


Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection

Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 50 mg/10 mL (5 mg/mL 1:200,000) (NDC 0409-1749-10)


Clonazepam, Tablet, .5 mg (NDC 59651-722-01)


Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 11534-196-01)


Etomidate, Injection, 2 mg/1 mL (NDC 72572-160-10)


Solu-cortef, Injection, 250 mg/vial (NDC 0009-0013-05)


Lisdexamfetamine Dimesylate Tablet, Chewable

Vyvanse, Tablet, Chewable, 30 mg (NDC 59417-117-01)


DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE


Limited Supply Available. Next Delivery: August 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay

Demerol, Injection, 50 mg/1 mL (NDC 0409-1178-30)


Naropin, Injection, 2 mg/1 mL (NDC 63323-285-63)


Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 6 mg/1 mL (NDC 0781-3288-09)


Docetaxel, Injection, 160 mg/16 mL (10 mg/mL) Multiple Dose ONCO-TAIN™ Glass Fliptop Vial Novaplus®  (NDC 0409-0016-01)


Naropin, Injection, 2 mg/1 mL (NDC 63323-285-20)


Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 71225-126-06)


Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-7517-16)


Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 43547-603-10)


Testosterone, Gel; Gel, Metered, 16.2 mg/1 g (NDC 0591-2925-30)


Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-467-57)


Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-30)


Fentanyl Citrate, Injection, 500 mcg/10 mL (50 ug/1 mL) (NDC 0409-9094-28)


Next release May 2026. Check wholesalers for inventory.

Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-05)


Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 64850-503-01)


Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-201-10)


Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (NDC 57664-086-88)


Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 47781-568-01)


INTRAMUSCULAR INTRATHECAL INTRAVENOUS SUBCUTANEOUS

Methotrexate Sodium, Injection, 1 g/40 mL (25 mg/mL) (NDC 61703-124-40)


Dextrose Monohydrate 5%, Injection, 5 g/100 mL (NDC 0264-7510-20)


Atropine Sulfate, Injection, 1 mg/1 mL (NDC 0517-1001-25)


Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay

BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE

Bupivacaine Hydrochloride and Epinephrine, Injection, 125 mg/50 mL (2.5 mg/mL) (NDC 0409-9043-01)


Discontinuation of the manufacture of the drug

Omeprazole, Delayed Release Capsule, 10 mg (NDC 0781-2859-31)


Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-00)


On backorder. Recovery: TBD. Check wholesalers for inventory

INTRA-ARTICULAR
INTRALESIONAL
INTRAMUSCULAR
SOFT TISSUE

Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 55150-314-01)


Guanfacine Hydrochloride Tablet, Extended Release

Guanfacine Hydrochloride, Tablet, Extended Release, 2 mg (NDC 0228-2851-11)


Ketamine Hydrochloride, Injection, 500 mg/5mL (100 mg/mL); Multiple Dose Glass Fliptop Vial Novaplus (NDC 0409-0040-10)


Docetaxel, Injection, 10 mg/1 mL (NDC 50742-431-08)


Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-27)


Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 13107-070-01)


Euthyrox, Tablet, 112 ug (NDC 72305-112-30)


Naltrexone Hydrochloride, Tablet, 50 mg (NDC 47335-326-88)


Pilocarpine Hydrochloride Ophthalmic Solution

Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-06)


Bupivacaine Hydrochloride, Injection, 0.25%; 75 mg/30 mL (2.5 mg/mL) (NDC 0409-1159-10)


Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-91)


Discontinuation of the manufacture of the drug; Expiry date of last distributed batch October 2026

Pindolol, Tablet, 10 mg (NDC 57664-656-88)


Company Contact: 609-395-8625 ext. 203 (US Agent eVenus Pharmaceutical Laboratories, Inc.)

Discontinuation of the manufacture of the drug; Distributed by Sagent Pharmaceuticals

Irinotecan Hydrochloride, Injection, 100 mg/5 mL (NDC 25021-230-05)


Meperidine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-6052-25)


Naropin, Injection, 10 mg/1 mL (NDC 63323-288-11)


3, 4, 5, 7 & 8 month expiry available upon request. Check wholesaler for inventory

BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE

Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-468-17)


Lidocaine Hydrochloride and Epinephrine, Injection, 600 mg/30 mL (2%; 1:100,000) (NDC 0409-3182-02)


Acetaminophen; Oxycodone Hydrochloride Tablet

Acetaminophen; Oxycodone Hydrochloride, Tablet, 325 mg; 5 mg (NDC 60951-602-85)


Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (NDC 72205-133-91)


Additional lots will be scheduled for manufacturing. Product will be made available as it is released.

Sterile Water, Injection, 1 mL/1 mL (NDC 0641-6147-10)


Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-15)


Next release June 2026.  Check wholesalers for inventory.

Dilaudid, Injection, 2 mg/1 mL (NDC 76045-010-11)


Lidocaine Hydrochloride, Injection, 100 mg/5 mL (2%; 20 mg/mL) (NDC 0409-2066-05)


Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 47781-562-01)


Hyrimoz, Injection, 80 mg/.8 mL (NDC 61314-454-36)


Vyvanse, Capsule, 20 mg (NDC 59417-102-10)


Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-03)


Additional lots are scheduled to be manufactured. Product will be made available as it is released.

Analgesia/Addiction Gastroenterology Pediatric Pulmonary/Allergy

Phenergan, Injection, 50 mg/1 mL (NDC 0641-6085-25)


Sensorcaine, Injection, 7.5 mg/1 mL (NDC 63323-472-37)


Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE

Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 42806-341-01)


Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-04)


EacNext release not available at this time; Shortage per Manufacturer: Product manufacturing interrupted due to testing

Tiglutik, Oral Suspension, 50 mg/10 mL (NDC 70726-0303-1)


Bupivacaine Hydrochloride And Epinephrine, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-9042-01)


Desipramine Hydrochloride, Tablet, 25 mg (NDC 23155-579-01)


Solu-cortef, Injection, 250 mg/vial (NDC 0009-0013-06)


Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 0406-8885-01)


Available. Distributed by Padagis US LLC

Methylphenidate, Film, Extended Release, 15 mg (NDC 0574-2415-65)


Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-02)


Klonopin, Tablet, 1 mg (NDC 61269-610-10)


Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 43066-555-24)


Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0406-5112-01)


Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 76329-3302-1)


Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.

Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-6254-01)


Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-50)


Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0066-20)


Distributed by Avenacy; Contact information: 877-283-6229

Furosemide, Injection, 10 mg/1 mL (NDC 83634-302-10)


Morphine Sulfate, Injection, 5 mg/10 mL (0.5 mg/mL) (NDC 0409-3814-12)


Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-17)


Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-463-57)


Dexamethasone Sodium Phosphate Injection

Additional product will be made available as it is released.

Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6146-25)


Clonazepam, Tablet, 1 mg (NDC 0093-3212-05)


Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-17)


Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-03)


Precedex, Injection, 200 mcg/2 mL (100 mcg/mL) (NDC 0409-1638-02)


On Allocation. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7922-09

Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-09)


Ethinyl Estradiol; Etonogestrel, Ring, .015 mg/1 d; .12 mg/1 d (NDC 0093-7679-02)


Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0054-0372-25)


Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-722-32)


Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-251-10)


Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0527-4663-37)


Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-06)


Clonazepam, Tablet, 1 mg (NDC 59651-723-99)


On Allocation. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7930-03

Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-03)


Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-03)


Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 57664-087-88)


Vitamin D2 Analog [EPC]
Vitamin D Analog [EPC]

Zemplar, Capsule, 1 ug (NDC 0074-9036-30)


Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 71288-728-32)


LEUCINE, LYSINE, ISOLEUCINE, VALINE, HISTIDINE, PHENYLALANINE, THREONINE, METHIONINE, TRYPTOPHAN, TYROSINE, N-ACETYL-TYROSINE, ARGININE, PROLINE, ALANINE, GLUTAMIC ACIDE, SERINE, GLYCINE, ASPARTIC ACID, TAURINE, CYSTEINE HYDROCHLORIDE

Premasol 10% Sulfite Free in VIAFLEX Plastic Container, Injection, 0.1 (NDC 0338-1130-04)


Gilead plans to sell through the end of February 2026. Discontinuation of the manufacture of the drug due to business reasons.

Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]

Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]

Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]


Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 47781-566-01)


Cefotaxime Sodium, Powder, for Solution, 2 g (NDC 21586-012-02)


Furosemide, Injection, 10 mg/1 mL; 4mL vial (NDC 83634-302-04)


Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 42858-164-01)


Allopurinol, Tablet, 300 mg (NDC 0591-5544-05)


Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0527-0761-37)


Quinapril Hydrochloride, Tablet, 5 mg (NDC 68180-556-09)


Sterile Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 63323-185-20)


LEUCINE, PHENYLALANINE, LYSINE HYDROCHLORIDE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, TYROSINE, SERINE


Clonazepam, Tablet, 2 mg (NDC 72888-154-05)


Desmopressin Acetate, Spray, 10 ug/.1 mL (NDC 69918-501-05)


Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0378-6856-77)


Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0480-3568-01)


Clonazepam, Tablet, 1 mg (NDC 72888-153-00)


A business decision was made to discontinue manufacture of the drug.

Docetaxel, Injection, 10 mg/1 mL (NDC 50742-463-16)


Furosemide, Injection, 10 mg/mL, 2 mL (NDC 71288-205-03)


Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 63323-202-02)


Discontinuation of the manufacture of the drug.


Sufentanil Citrate, Injection, 50 ug/1 mL (NDC 0409-3382-21)


Azelastine Hydrochloride; Fluticasone Propionate Nasal Spray

Discontinuation of the manufacture of the drug

AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE

AZELASTINE HYDROCHLORIDE
FLUTICASONE PROPIONATE

Azelastine Hydrochloride; Fluticasone Propionate, Nasal Spray, 137 ug; 50 ug (NDC 0378-3458-23)


Dexmedetomidine Hydrochloride, Injection, 4 mcg/mL, 50 mL (NDC 70121-1388-1)


Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6043-25)


Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (NDC 72205-135-91)


Methylphenidate Hydrochloride Tablet, Extended Release

Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 62037-726-01)


Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0304-1)


Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay

Bupivacaine Hydrochloride And Epinephrine, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC 0409-9042-17)


Acetaminophen; Oxycodone Hydrochloride, Tablet, 325 mg; 2.5 mg (NDC 60951-701-70)


Desipramine Hydrochloride, Tablet, 50 mg (NDC 23155-580-01)


Next Delivery: May 2026; Estimated Recovery: June 2026; Shortage per Manufacturer: Manufacturing Delay

Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 1,000 mg/250mL (400 mg/mL) (NDC 0409-3724-32)


Otrexup, Injection, 10 mg/.4 mL (NDC 82497-010-04)


Tiagabine Hydrochloride, Tablet, 12mg 30 count (NDC 0093-8072-56)


Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-461-57)


Discontinuation of the manufacture of the drug. Product expected to be available through September 2026.

Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]

Synagis, Injection, 50 mg/.5 mL (NDC 66658-230-01)


Pravastatin Sodium, Tablet, 80 mg (NDC 0480-7270-10)


Discontinuation of the manufacture of the drug product

Tazverik, Tablet, 200 mg (NDC 72607-100-00)


Inventory available at Cardinal Health, McKesson, Cencora (FKA Amerisource Bergen). Product (LIDOCAINE HCL 4% 10X5ML)  is Preservative free.

Lidocaine Hydrochloride, Injection, 40 mg/1 mL (NDC 83090-007-10)


Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 64850-551-01)


Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 65862-163-90)


Check wholesalers for inventory; Marketed by Fresenius Kabi 800-551-7176

Etomidate, Injection, 2 mg/mL (NDC 65219-447-20)


On backorder. Recovery: TBD. Check wholesalers for inventory

Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 55150-313-01)


Adderall, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 57844-120-01)


Rifampin, Injection, 600 mg (NDC 63323-351-20)


Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-10)


Corlanor, Solution, 5 mg/5 mL (NDC 55513-813-28)


Next release May 2026. Check wholesalers for inventory.

Naropin, Injection, 2 mg/1 mL (NDC 63323-285-13)


Clonazepam, Tablet, 1 mg (NDC 16729-137-16)


Not available. Long-term backorder for all NDCs. No estimated release date at this time.

Quinapril Hydrochloride, Tablet, 20 mg (NDC 43547-412-09)


Lidocaine Hydrochloride And Dextrose, Injection, 8 mg/1 mL (NDC 0338-0411-02)


Clonazepam, Tablet, 2 mg (NDC 72888-154-30)


Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-31)


Discontinuation of the manufacture of the drug. Supply expected to exhaust in August 2023

Minipress, Capsule, 1 mg (NDC 0069-4310-71)


Limited Supply Available. Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay

Cleocin Phosphate, Injection, 900 mg/6 mL (150 mg/mL) (NDC 0009-5095-06)


Desipramine Hydrochloride, Tablet, 75 mg (NDC 23155-581-01)


Methotrexate Preservative Free, Injection, 1 g (NDC 63323-122-50)


Accupril, Tablet, 5 mg (NDC 0071-0527-23)


Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-422-54)


Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-462-10)


Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]

Etravirine, Tablet, 100 mg (NDC 10147-0570-1)


Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 43547-604-10)


Echothiophate Iodide Ophthalmic Solution

Available through limited distribution by Walgreens Specialty Pharmacy.

ECHOTHIOPHATE IODIDE FOR OPHTHALMIC SOLUTION

Phospholine Iodide, Ophthalmic Solution, 0.125% (NDC 48102-053-05)


Technetium TC-99M Pyrophosphate Kit Injection

Technescan PYP, Injection, 11.9 mg/10 mL; 3.2 mg/10 mL (NDC 69945-094-20)


Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-725-32)


Fluvastatin Sodium Tablet, Extended Release

Fluvastatin Sodium, Tablet, Extended Release, 80 mg (NDC 0781-8017-31)


Lidocaine Hydrochloride, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4278-01)


Kyxata, Injection, 80 mg/8 mL (10 mg/mL) (NDC 83831-141-08)


Nebivolol Hydrochloride, Tablet, 2.5 mg (NDC 13668-353-30)


Additional lots will be scheduled for manufacturing to meet demand.  Product will be made available as it is released.

Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6029-25)


Guanfacine Hydrochloride, Tablet, Extended Release, 4 mg (NDC 0228-2855-11)


Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 42858-162-01)


This presentation is temporarily on backorder.

Phenergan, Injection, 25 mg/1 mL (NDC 0641-6084-25)


Epinephrine Bitartrate, Lidocaine Hydrochloride Injection

Next Delivery: June 2026; Estimated Recovery: September 2026; Shortage per Manufacturer: Manufacturing Delay

Adrenergic alpha-Agonists [MoA]
Adrenergic beta-Agonists [MoA]

Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:200,000) (NDC 0409-3183-01)


Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-84)


Unbranded Insulin Degludec 3 mL U-100 FlexTouch® will continue to be shipped to wholesalers while supplies last, up until the discontinuation dates. Full discontinuation will occur on December 31, 2025.

Insulin Degludec, Injection, 3 mL Insulin Degludec 100 units/mL (U-100) FlexTouch® (NDC 73070-403-15)


Currently Inventory available 4 to 6 weeks as per current demand. Next supply: week of 02/09/2026

Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 70121-1573-1)


Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 65162-027-09)


Discontinuation of the manufacture of the drug; Distributed by Sandoz Inc.

Fondaparinux Sodium, Injection, 10 mg/.8 mL (NDC 0781-3476-95)


Naltrexone Hydrochloride, Tablet, 50 mg (NDC 68094-909-50)


Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-99)


Sterile Water, Irrigant, 100 mL/100 mL (NDC 0338-0004-04)


Discontinuation of the manufacture of the drug

Desipramine Hydrochloride, Tablet, 100 mg (NDC 23155-582-01)


Tazicef, Injection, 2 g (NDC 0409-5093-11)


Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 44567-603-24)


Furosemide, Injection, 10 mg/1 mL (NDC 16729-501-43)


Morphine Sulfate, Injection, 2 mg/1 mL Syringes (NDC 0409-1890-01)


Discontinuation of the manufacture of the drug.

Pemetrexed Ditromethamine, Injection, 100 mg Single Dose Vial (NDC 0409-1060-01)


Meperidine Hydrochloride, Injection, 100 mg/1 mL (NDC 0641-6054-25)


Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 70010-111-01)


Product in transit, expected to arrive last week of April 2026

Bumetanide, Injection, .25 mg/1 mL (NDC 25021-321-10)


Amlodipine Besylate; Benazepril Hydrochloride Capsule

Permanent discontinuation in the manufacturing of the drug

AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE


Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 63323-808-11)


Inventory available 4 to 8 weeks as per current demand. Next supply: week of 2/23/2026

Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 70121-1389-7)


Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-20)


Furosemide, Injection, 10 mg/1 mL (NDC 36000-282-25)


Limited Supply Available. Next Delivery: May 2026; Estimated Recovery: June 2026; Shortage per Manufacturer: Manufacturing Delay

Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-3365-10)


Oxaliplatin, Injection, 5 mg/1 mL (NDC 0781-3315-70)


Naropin, Injection, 2 mg/1 mL (NDC 63323-285-23)


Albuterol 0.5% is in stock, though demand remains high; additional supply can be produced as needed.

Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 0487-9901-30)


Lidocaine Hydrochloride And Epinephrine, Injection, 500 mg/50 mL (1%; 1:100,000) (NDC 0409-3178-03)


Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0406-5114-01)


Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-25)


Lisdexamfetamine Dimesylate Tablet, Chewable

Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (NDC 57664-088-88)


Ampicillin Sodium, Injection, 2 g (NDC 0781-9408-95)


A business decision was made to discontinue manufacture of the drug.

Lyumjev, Injection, U-100 Tempo Pen Sample (NDC 0002-8235-99)


Currently Inventory available 4 to 8 Weeks as per current demand. Next supply: week of 03/16/2026

Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 70121-1574-1)


Mark Cuban Cost Plus Drug Company: 682-428-8081

Lentocilin, Injection, 1200000 U/4 mL (NDC 84383-110-01)


Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-82)


Fondaparinux Sodium, Injection, 5 mg/.4 mL (NDC 0781-3454-95)


Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10)


Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 42806-339-01)


Pravastatin Sodium, Tablet, 40 mg (NDC 0093-7202-98)


Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 55150-296-10)


Naltrexone Hydrochloride, Tablet, 50 mg (NDC 62135-242-60)


Next release May 2026. Check wholesalers for inventory.

Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 63323-083-05)


Additional lots are scheduled to be manufactured. Product will be made available as it is released.

Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6056-10)


Next Delivery: May 2026; Estimated Recovery: June 2026; Check Wholesaler for Availability; Shortage per Manufacturer: Manufacturing Delay

Endocrinology/Metabolism
Gastroenterology
Pediatric
Total Parenteral Nutrition

Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-06)


Phenobarbital, Tablet, 16.2 mg (NDC 0603-5165-32)


Heparin Sodium, Injection, 2,000 Units/1,000 mL (2 Units/mL) (NDC 0409-7620-59)


Sterile Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 63323-185-10)


Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 42806-345-01)


Allocation to current contracted customers

Methylphenidate Hydrochloride, Tablet, Extended Release, 45 mg (NDC 13811-711-30)


Avet Pharmaceuticals, Inc.: 855-228-9470; Sagent Pharmaceuticals: 866-625-1618

Estimated recovery: TBD; Distributed by Sagent Pharmaceuticals

Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-661-10)


Pilocarpine Hydrochloride Ophthalmic Solution

Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-01)


Limited Supply Available. Next Delivery: May 2026; Estimated Recovery: September 2026

Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-339-22)


Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-1495-35)


Atropine Sulfate, Injection, .05 mg/1 mL (NDC 16729-483-03)


Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE

Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 72516-014-01)


Supply is expected to be depleted by 12/31/2025.

Parnate, Tablet, 10 mg (NDC 0591-5590-01)


Next Delivery: May 2026; Estimated Recovery: June 2026; Shortage per Manufacturer: Manufacturing Delay

Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 500 mg/250mL (200 mg/mL) (NDC 0409-2347-32)


Discontinuation of the manufacture of the drug

Euthyrox, Tablet, 175 ug (NDC 72305-175-30)


Cytochrome P450 3A4 Inhibitors [MoA]
Cytochrome P450 2C19 Inhibitors [MoA]
Cytochrome P450 2C9 Inhibitors [MoA]

Vfend, Injection, 10 mg/1 mL (NDC 0049-3190-01)


Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-02)


Lidocaine Hydrochloride, Injection, 40 mg/2 mL (2%; 20 mg/mL) (NDC 0409-4282-01)


Dibenzyline, Capsule, 10 mg (NDC 59212-001-01)


Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02)


Ketorolac Tromethamine, Tablet, 10 mg (NDC 0378-1134-01)


Lidocaine Hydrochloride, Injection, 50 mg/5mL (1%,10 mg/1 mL) Syringes (NDC 0409-4904-34)


Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 47781-567-01)


Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-02)


Naltrexone Hydrochloride, Tablet, 50 mg (NDC 51224-206-50)


Concerta, Tablet, Extended Release, 54 mg (NDC 50458-587-01)


Duramorph, Injection, .5 mg/1 mL (NDC 0641-6020-10)


Riboflavin 5-phosphate  Ophthalmic Solution

Discontinuing manufacture of the product as of June 2026.

Photrexa Cross-linking Kit, Ophthalmic Solution, Kit (NDC 25357-025-03)


Bacitracin, Ophthalmic Ointment, 3.5 g (NDC 0574-4022-35)


Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 64980-642-03)


Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil Tablet

A business decision was made to discontinue manufacture of the product.

Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil, Tablet, 5 mg; 25 mg; 40 mg (NDC 13668-385-90)


Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-22)


Phenobarbital, Tablet, 64.8 mg (NDC 0603-5167-32)


Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0555-0971-02)


The global Cease Manufacture date for EVOTAZ® currently is estimated to begin April 2026.


Sodium Chloride 0.9% in Plastic Container, Injection, 900 mg/100 mL (NDC 49230-300-10)


Hydromorphone Hydrochloride Injection, USP CII, Injection, 10 mg/1 mL (NDC 0703-0113-03)


Available. Distributed by Padagis US LLC

Methylphenidate, Film, Extended Release, 20 mg (NDC 0574-2420-65)


Potassium Chloride Tablet, Extended Release

Discontinuation of the manufacture of the drug product

Potassium Chloride, Tablet, Extended Release, 750 mg (NDC 0832-5323-10)


Estimated recovery: end of June 2026; Distributed by BPI Labs, LLC

Carboplatin, Injection, 450mg/45mL (NDC 54288-166-01)


Discontinuation of the manufacture of the drug.

Cefepime Hydrochloride, Injection, 2 g (NDC 63323-340-20)


Etomidate, Injection, 2 mg/1 mL (NDC 67457-903-20)


Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-01)


Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection

Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay

BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE

Bupivacaine Hydrochloride And Epinephrine, Injection, 250 mg/50 mL (5 mg/mL) (NDC 0409-9046-01)


Clindamycin Palmitate Hydrochloride Injection

CLINDAMYCIN PALMITATE HYDROCHLORIDE (PEDIATRIC)

Clindamycin Palmitate Hydrochloride, Injection, 75 mg/5 mL (NDC 53746-468-19)


LIDOCAINE HYDROCHLORIDE ANHYDROUS AND DEXTROSE MONOHYDRATE

Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-10)


Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0054-0660-25)


Dexamethasone Sodium Phosphate Injection

Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 63323-506-01)


Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3671-01)


Permanent discontinuation in the manufacturing of the drug

Metoprolol Tartrate, Tablet, 50 mg (NDC 65862-063-59)


Naropin, Injection, 2 mg/1 mL (NDC 65219-632-10)


Bupivacaine Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-1162-01)


On Allocation. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7923-13

Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-13)


Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0110-03)


Corlanor, Tablet, eq. 5 mg base (NDC 55513-800-60)


Additional lots will be available in the May 2026 timeframe.  Product will be made available as it is released.

Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 0641-6262-01)


Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-10)


Tiagabine Hydrochloride, Tablet, 4mg 30 count (NDC 0093-5031-56)


Wholesaler & Distributor through Marketing partner (Apotex Inc.)

Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-6)


Finasteride, Tablet, 5 mg (NDC 0093-7355-56)


Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 71357-002-10)


Bumetanide, Injection, .25 mg/1 mL (NDC 72205-102-07)


Lorazepam, Injection, 2 mg/1 mL (NDC 76329-8261-1)


Currently Inventory available 2 to 4 Weeks as per current demand. Next supply: week of 02/09/2026

Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 70121-1574-5)


Phenobarbital, Tablet, 64.8 mg (NDC 0603-5167-21)


Quinapril Hydrochloride, Tablet, 20 mg (NDC 68180-558-09)


Corticosteroid Hormone Receptor Agonists [MoA]

Triesence, Injection, 40 mg/1 mL (NDC 82667-800-01)


Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-7)


Clonazepam, Tablet, 2 mg (NDC 16729-138-16)


Precedex, Injection, 80 mcg/20 mL (4 mcg/mL) (NDC 0409-1660-20)


Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-12)


Phenobarbital, Tablet, 32.4 mg (NDC 0603-5166-21)


Potassium Chloride, Tablet, Extended Release, 20 meq (NDC 62037-720-05)


Reyataz, Capsule, 200 mg (NDC 0003-3631-12)


Celecoxib, Capsule, 50 mg (NDC 0591-3982-60)


Clonazepam, Tablet, .5 mg (NDC 0093-0832-01)


Distributed by Omnivium Pharmaceuticals LLC (888) 807-9195 or customerservice@omniviumpharma.com

No longer manufactured, some supplies still available in supply chain. Distributed by Ritedose Pharmaceuticals, LLC (855) 806 3300

CROMOLYN SODIUM ORAL SOLUTION (CONCENTRATE)

Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 76204-025-96)


Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-10)


Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil, Tablet, 10 mg; 25 mg; 40 mg (NDC 13668-382-05)


On allocation. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7120-07

DEXTROSE 70% IN PLASTIC CONTAINER, Injection, 70 g/100 mL (NDC 0990-7120-07)


Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 57664-050-88)


Cleocin Phosphate, Injection, Cleocin Phosphate 600 mg/4 mL (150 mg/mL) (NDC 0009-0775-26)


Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil, Tablet, 10 mg; 25 mg; 40 mg (NDC 13668-382-90)


Next Delivery: September 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay

Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 0409-1283-37)


Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-2305-17)


Naropin, Injection, 5 mg/1 mL (NDC 63323-286-63)


Gastrocrom, Concentrate, 20 mg/1 mL (NDC 0037-0678-96)


Slate Run Pharmaceuticals, LLC: 844-529-8988

Distributed by Slate Run Pharmaceuticals, LLC, 1-844-529-8988

Dobutamine Hydrochloride, Injection, 250 mg/20 mL (NDC 70436-203-80)


Estimated recovery: TBD; Distributed by Sagent Pharmaceuticals

Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 25021-655-02)


Klor-Con, Tablet, Extended Release, 750 mg (NDC 0245-5316-15)


Vidaza, Injection, 100 mg (NDC 59572-102-01)


Discontinuation of the manufacture of the drug

Cleocin Hydrochloride, Capsule, 150 mg (NDC 0009-0225-02)


Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay

Furosemide, Injection, 40 mg/4 mL (10 mg/1 mL) (NDC 0409-6102-26)


Pravastatin Sodium, Tablet, 10 mg (NDC 0093-0771-10)


Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6145-25)


Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/250 mL (1.6 mg/1 mL) (NDC 0409-7809-22)


Everolimus, Tablet, 10 mg (NDC 0093-7769-24)


Furosemide, Injection, 40 mg/4 mL (10 mg/1 mL) (NDC 0409-6102-04)


Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.

Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 0143-9575-10)


Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 65162-025-09)


Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-061-25)


Tracleer, Tablet, 125 mg (NDC 66215-102-03)


Intelence, Tablet, 100 mg (NDC 59676-570-01)


Aldactone, Tablet, 100 mg (NDC 0025-1031-31)


Atropine Sulfate, Injection, .1 mg/1 mL (NDC 16729-484-90)


Clonazepam, Tablet, .5 mg (NDC 72888-152-01)


Next release June 2026. Check wholesalers for inventory.

Dilaudid, Injection, .2 mg/1 mL (NDC 76045-121-11)


Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3678-01)


The NDC codes are being discontinued, to be replaced with NDC labeler code #46163.

DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE

DELFLEX® w/Dextrose, Solution, 4.25% Low Mg/Low Ca 2L, 5/cs (NDC 46163-212-92)


Quinapril Hydrochloride, Tablet, 10 mg (NDC 62135-485-90)


Calcium Chloride, Injection, 100 mg/1 mL (NDC 0409-4928-34)


Glucatrol XL, Tablet, Extended Release, 10 mg tablets; bottle of 500 (NDC 0049-0178-08)


Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-01)


BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE

Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 150 mg/30 mL (5 mg/mL 1:200,000) (NDC 0409-1749-29)


Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-02)